TOXICITY TESTING OF POLYMER MATERIALS FOR DIALYSIS EQUIPMENT - IS THERE ANY NEED FOR IN-VIVO TESTING

Citation
P. Kjellstrand et al., TOXICITY TESTING OF POLYMER MATERIALS FOR DIALYSIS EQUIPMENT - IS THERE ANY NEED FOR IN-VIVO TESTING, Cell biology and toxicology, 10(2), 1994, pp. 137-142
Citations number
15
Categorie Soggetti
Cytology & Histology",Toxicology
Journal title
ISSN journal
07422091
Volume
10
Issue
2
Year of publication
1994
Pages
137 - 142
Database
ISI
SICI code
0742-2091(1994)10:2<137:TTOPMF>2.0.ZU;2-H
Abstract
In an earlier work, slightly more than 650 plastic materials, intended for use in medical devices, were tested with a battery of chemical, a s well as in vitro and in vivo biological tests. An analysis showed th at only a limited number of the tests used were actually necessary to obtain the same pass or fail decision as that obtained using the full test battery. This prompted us to prescreen all new materials with a s mall test battery consisting of the two most discriminating chemical t ests and an in vitro cell growth inhibition test. The present work is a report of our findings after testing another 155 materials using thi s prescreen system. For each single one of the 155 tested materials th e same decision on whether or not to use the material in the intended medical device would have been reached without any in vivo testing. In no single case in a total of 851 in vivo tests did an eluate that had passed the in vitro cell test give rise to a reaction in vivo. Thus, among the tests on living systems, the cell test alone seems to be sen sitive enough to provide sufficient information. Nothing appears to be gained from the in vivo animal tests. However, some of the materials that passed the prescreening tests later failed in one or several of t he chemical tests. Both nonspecific chemical tests and tests for speci fic molecules seem to detect undesirable levels of leachable substance s not detected by the prescreening system. Therefore these tests shoul d not be abandoned. Abandoning unnecessary in vivo testing, on the oth er hand, would save considerable costs.